Anbio Biotechnology (NNNN) Operating income 2022–2025
Anbio Biotechnology (NNNN) annual operating income history from SEC filings — each fiscal year as reported.
$5.8MFY2025 · since FY2022: $10.2M → $5.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $5.8M | +189.1% |
| FY2024 | $2.0M | +1.8% |
| FY2023 | $2.0M | -80.8% |
| FY2022 | $10.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More NNNN financial trends
NNNN RevenueNNNN Net incomeNNNN Net marginNNNN Gross profitNNNN Gross marginNNNN Operating marginNNNN Operating cash flowNNNN Free cash flowNNNN Capital expendituresNNNN Return on equityNNNN Stock buybacksNNNN Dividends paidNNNN Total assetsNNNN Total liabilitiesNNNN Shareholders’ equityNNNN overview →